Title |
Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases
|
---|---|
Published in |
Basic Research in Cardiology, December 2017
|
DOI | 10.1007/s00395-017-0663-9 |
Pubmed ID | |
Authors |
Dongling Liu, Xiang Zeng, Xiao Li, Jawahar L. Mehta, Xianwei Wang |
Abstract |
NLRP3 inflammasome is a key multiprotein signaling platform that tightly controls inflammatory responses and coordinates antimicrobial host defenses by activating caspase-1 for the subsequent maturation of pro-inflammatory cytokines, IL-1β and IL-18, and induces pyroptosis. The assembly and activation of NLRP3 inflammasome are linked to the pathogenesis of several cardiovascular disease risk factors, such as hypertension and diabetes, and their major consequences-myocardial remodeling. The study of the NLRP3 inflammasome in these cardiovascular disease states may uncover important triggers and endogenous modulators of the disease, and lead to new treatment strategies. This review outlines current insights into NLRP3 inflammasome research associated with cardiovascular diseases and discusses the questions that remain in this field. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 121 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 15 | 12% |
Student > Ph. D. Student | 13 | 11% |
Researcher | 12 | 10% |
Student > Bachelor | 11 | 9% |
Student > Postgraduate | 7 | 6% |
Other | 19 | 16% |
Unknown | 44 | 36% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 29 | 24% |
Biochemistry, Genetics and Molecular Biology | 15 | 12% |
Immunology and Microbiology | 8 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
Agricultural and Biological Sciences | 4 | 3% |
Other | 10 | 8% |
Unknown | 50 | 41% |